Literature DB >> 16085140

Mechanism of interaction of the non-steroidal antiinflammatory drugs meloxicam and nimesulide with serum albumin.

Neelam Seedher1, Sonu Bhatia.   

Abstract

The mechanism of interaction of the non-steroidal antiinflammatory drugs meloxicam and nimesulide with human and bovine serum albumin has been studied using fluorescence spectroscopy. There was only one high affinity site on serum albumin for both the drugs with association constants of the order of 10(5). Negative enthalpy (DeltaH(0)) and positive entropy (DeltaS(0)) values in the case of both meloxicam and nimesulide showed that both hydrogen bonding and hydrophobic interactions play a role in the binding of these drugs. Binding studies in the presence of the hydrophobic probe 1-anilinonaphthalene-8-sulfonate (ANS) showed that the binding of meloxicam and nimesulide to serum albumin involves predominantly hydrophobic interactions. Stern-Volmer analysis of the quenching data showed that quenching is highly efficient and that the tryptophan residues in hydrophobic regions of the proteins are fully exposed to the drugs. Thus these drugs are bound to albumin by hydrophobic interactions as well as hydrogen bonding at a site, which is close to the tryptophan residues. An increase of the pH and ionic strength caused an increase in the concentration of free drug, although the effect was not very significant.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16085140     DOI: 10.1016/j.jpba.2005.02.031

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  6 in total

1.  Determination of meloxicam using europium sensitized luminescence in the presence of co-luminescence reagents.

Authors:  Salma Muhamed Z Al-Kindy; Salim K Al-Habsy; Fakhr Eldin O Suliman; Haidar A J Al-Lawati
Journal:  J Fluoresc       Date:  2011-09-22       Impact factor: 2.217

2.  Automated solid-phase microextraction and thin-film microextraction for high-throughput analysis of biological fluids and ligand-receptor binding studies.

Authors:  Dajana Vuckovic; Erasmus Cudjoe; Florin Marcel Musteata; Janusz Pawliszyn
Journal:  Nat Protoc       Date:  2010-01-07       Impact factor: 13.491

3.  Meloxicam-loaded nanocapsules as an alternative to improve memory decline in an Alzheimer's disease model in mice: involvement of Na(+), K(+)-ATPase.

Authors:  Francine R Ianiski; Catiane B Alves; Carla F Ferreira; Virginia C Rech; Lucielli Savegnago; Ethel A Wilhelm; Cristiane Luchese
Journal:  Metab Brain Dis       Date:  2016-02-27       Impact factor: 3.584

4.  Applicability of a newly developed bioassay for determining bioactivity of anti-inflammatory compounds in release studies--celecoxib and triamcinolone acetonide released from novel PLGA-based microspheres.

Authors:  Hsiao-yin Yang; Maarten van Dijk; Ruud Licht; Michiel Beekhuizen; Mattie van Rijen; Martina Källrot Janstål; F Cumhur Öner; Wouter J A Dhert; Detlef Schumann; Laura B Creemers
Journal:  Pharm Res       Date:  2014-08-28       Impact factor: 4.200

5.  Characterization and In Vitro Skin Permeation of Meloxicam-Loaded Liposomes versus Transfersomes.

Authors:  Sureewan Duangjit; Praneet Opanasopit; Theerasak Rojanarata; Tanasait Ngawhirunpat
Journal:  J Drug Deliv       Date:  2010-11-07

Review 6.  Study on the interaction between active components from traditional Chinese medicine and plasma proteins.

Authors:  Qishu Jiao; Rufeng Wang; Yanyan Jiang; Bin Liu
Journal:  Chem Cent J       Date:  2018-05-04       Impact factor: 4.215

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.